Thermo Fisher Scientific has expanded its API manufacturing capabilities having completed its acquisition of an active pharmaceutical ingredient (API) manufacturing facility from GlaxoSmithKline (GSK). Approximately 400 employees at the Cork, Ireland, site will become part of Thermo Fisher’s Pharma Services API business.   The Cork site will join 1300 colleagues across Thermo Fisher’s expanded API network of manufacturing facilities in Florence and Greenville, SC; Linz, Austria; and Regensburg, ...